{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:42:50Z","timestamp":1784122970879,"version":"3.55.0"},"reference-count":63,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2025,12,16]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Sarcopenia, characterised by reduced skeletal muscle mass and strength, is increasingly recognised as a prognostic marker in oncology. Its role in breast cancer and its variation across molecular subtypes remains unclear. This study examined the prognostic value of sarcopenia, defined by Skeletal Muscle Index (SMI), and its association with overall survival (OS) among breast cancer subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 523\u2009women diagnosed with breast cancer at Ege University between January 2014 and January 2015. Clinical, pathological and anthropometric data were collected. Sarcopenia was evaluated using bioelectrical impedance analysis (BIA) with the TANITA SC-330 device to estimate appendicular muscle mass, and defined as SMI &lt;5.5\u2009kg\/m\u00b2. Survival outcomes were analysed using Kaplan\u2013Meier curves and Cox regression models adjusted for age, tumour stage, molecular subtype and body mass index. Subgroup analyses were performed for luminal A, luminal B, HER2-positive and triple-negative breast cancer (TNBC) subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age was 57.6\u00b113.0 years, and 9.7% were sarcopenic. Sarcopenia was significantly associated with reduced OS (HR: 1.789, p=0.025). While no significant effect was seen in luminal A or B subtypes, sarcopenia predicted markedly worse survival in HER2-positive patients (HR: 11.247, p=0.001) and TNBC patients. Recurrence rates were similar between sarcopenic and non-sarcopenic individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Sarcopenia assessed by BIA is an independent predictor of poor survival in breast cancer, particularly in HER2-positive and TNBC subtypes. Incorporating muscle assessment into routine evaluation may help identify high-risk patients and guide supportive care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2025-005991","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T23:45:17Z","timestamp":1767224717000},"page":"363-374","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Skeletal muscle index as a prognostic biomarker for survival in HER2-positive and triple-negative breast cancer: a retrospective cohort study"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4075-7775","authenticated-orcid":false,"given":"O\u011fuzcan","family":"\u00d6zkan","sequence":"first","affiliation":[{"name":"Medical Oncology Department, Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131","family":"Ge\u00e7gel","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Erol","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"G\u00f6kmen","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Hopanc\u0131 B\u0131\u00e7akl\u0131","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"2026022702201295000_16.2.363.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708"},{"key":"2026022702201295000_16.2.363.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1101540"},{"key":"2026022702201295000_16.2.363.3","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-0195985-6"},{"key":"2026022702201295000_16.2.363.4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4161\/cbt.9.4.10659","article-title":"Traditional and new prognosticators in breast cancer: Nottingham index, Mib-1 and estrogen receptor signaling remain the best predictors of relapse and survival in a series of 289 cases","volume":"9","author":"Megha","year":"2010","journal-title":"Cancer Biology & Therapy"},{"key":"2026022702201295000_16.2.363.5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajcnut.2024.05.016","article-title":"Anthropometrics and cancer prognosis: a multicenter cohort study","volume":"120","author":"Chen","year":"2024","journal-title":"Am J Clin Nutr"},{"key":"2026022702201295000_16.2.363.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02470-0"},{"key":"2026022702201295000_16.2.363.7","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-0200"},{"key":"2026022702201295000_16.2.363.8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.clnu.2017.05.017","article-title":"The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer","volume":"37","author":"McSorley","year":"2018","journal-title":"Clin Nutr"},{"key":"2026022702201295000_16.2.363.9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamaoncol.2019.4668","article-title":"Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer","volume":"6","author":"Cespedes Feliciano","year":"2020","journal-title":"JAMA Oncol"},{"key":"2026022702201295000_16.2.363.10","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-016-0512-2"},{"key":"2026022702201295000_16.2.363.11","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35799","article-title":"Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types","volume":"131","author":"Mastrolonardo","year":"2025","journal-title":"Cancer"},{"key":"2026022702201295000_16.2.363.12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10549-025-07678-7","article-title":"The effect of body mass index on breast cancer stage and breast cancer specific survival","volume":"211","author":"Bellini","year":"2025","journal-title":"Breast Cancer Res Treat"},{"key":"2026022702201295000_16.2.363.13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17010050","article-title":"Dose-Limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition-A Protocol for an Observational Cohort Study","volume":"17","author":"De Nys","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026022702201295000_16.2.363.14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.26502\/fjwhd.2644-288400127","article-title":"Predictive Values of Upper Extremity Function and Body Composition Parameters for Upper Extremity Lymphedema Occurring within 12 Months after Breast Cancer Surgery","volume":"7","author":"Okamichi","year":"2024","journal-title":"J Women\u2019s Health Dev 2024"},{"key":"2026022702201295000_16.2.363.15","doi-asserted-by":"publisher","DOI":"10.1159\/000521241"},{"key":"2026022702201295000_16.2.363.16","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy169"},{"key":"2026022702201295000_16.2.363.17","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.01045","article-title":"The Role of Inflammation in Age-Related Sarcopenia","volume":"8","author":"Dalle","year":"2017","journal-title":"Front Physiol"},{"key":"2026022702201295000_16.2.363.18","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-018-0835-y"},{"key":"2026022702201295000_16.2.363.19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/CH-211202","article-title":"Sarcopenia in the elderly versus microcirculation, inflammation status, and oxidative stress: A cross-sectional study","volume":"80","author":"Lopes","year":"2022","journal-title":"Clin Hemorheol Microcirc"},{"key":"2026022702201295000_16.2.363.20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.14283\/jfa.2017.35","article-title":"Impact of Sarcopenia on One-Year Mortality Among Older Hospitalized Patients with Impaired Mobility","volume":"7","author":"Pourhassan","year":"2018","journal-title":"The Journal of Frailty & Aging"},{"key":"2026022702201295000_16.2.363.21","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-022-01450-3"},{"key":"2026022702201295000_16.2.363.22","first-page":"181","article-title":"Techniques for the diagnosis of sarcopenia","volume":"11","author":"Rubbieri","year":"2014","journal-title":"Clin Cases Miner Bone Metab"},{"key":"2026022702201295000_16.2.363.23","doi-asserted-by":"crossref","DOI":"10.3390\/nu17050927","article-title":"Nutritional Status and Its Impact on Treatment Tolerance in Non-Small-Cell Lung Cancer Patients Receiving Osimertinib","volume":"17","author":"Barca-D\u00edez","year":"2025","journal-title":"Nutrients"},{"key":"2026022702201295000_16.2.363.24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12029-025-01206-y","article-title":"Preoperative Prediction of Sarcopenia in Patients Scheduled for Gastric and Colorectal Cancer Surgery","volume":"56","author":"Zhou","year":"2025","journal-title":"J Gastrointest Cancer"},{"key":"2026022702201295000_16.2.363.25","first-page":"3411","article-title":"The association between sarcopenia and quality of life in patients undergoing colorectal cancer surgery: an exploratory study","volume":"29","author":"Besson","year":"2021","journal-title":"Support Care Cancer"},{"key":"2026022702201295000_16.2.363.26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12609-024-00541-6","article-title":"Breast Cancer Subtypes: Clinicopathologic Features and Treatment Considerations","volume":"16","author":"Cobb","year":"2024","journal-title":"Curr Breast Cancer Rep"},{"key":"2026022702201295000_16.2.363.27","doi-asserted-by":"crossref","unstructured":"Joyce R , Visvader JE . Cells-of-Origin of Breast Cancer and Intertumoral Heterogeneity. A Guide to Breast Cancer Research: From Cellular Heterogeneity and Molecular Mechanisms to Therapy. 2025;151\u201365. doi:10.1007\/978-3-031-70875-6_9","DOI":"10.1007\/978-3-031-70875-6_9"},{"key":"2026022702201295000_16.2.363.28","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jcsm.12468","article-title":"Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis","volume":"10","author":"Ubachs","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026022702201295000_16.2.363.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-018-0882-2"},{"key":"2026022702201295000_16.2.363.30","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00384-018-3128-1","article-title":"Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis","volume":"33","author":"Sun","year":"2018","journal-title":"Int J Colorectal Dis"},{"key":"2026022702201295000_16.2.363.31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06986-z"},{"key":"2026022702201295000_16.2.363.32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.clnu.2024.06.014","article-title":"Prevalence and survival implications of malnutrition and sarcopenia in metastatic breast cancer: A longitudinal analysis","volume":"43","author":"Camilleri","year":"2024","journal-title":"Clin Nutr"},{"key":"2026022702201295000_16.2.363.33","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-012-0234-x"},{"key":"2026022702201295000_16.2.363.34","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026022702201295000_16.2.363.35","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.clon.2023.11.033","article-title":"Association between Sarcopenia and Survival in Patients Undergoing Gamma Knife Surgery for Brain Metastasis from Breast Cancer: A Retrospective Single-centre Cohort Study","volume":"36","author":"Sim","year":"2024","journal-title":"Clin Oncol"},{"key":"2026022702201295000_16.2.363.36","first-page":"316","article-title":"Exploring the Impact of Sarcopenia on Mortality in Breast Cancer Patients: A Comprehensive Systematic Review and Meta-Analysis","volume":"19","author":"Dai","year":"2024","journal-title":"Breast Care (Basel)"},{"key":"2026022702201295000_16.2.363.37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.breast.2016.10.014","article-title":"Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy","volume":"31","author":"Rier","year":"2017","journal-title":"Breast"},{"key":"2026022702201295000_16.2.363.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2021.12.014"},{"key":"2026022702201295000_16.2.363.39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5472\/marumj.1484705","article-title":"Evaluation of sarcopenia-associated survival in breast cancer with computed tomography-based pectoral muscle area measurements","volume":"37","author":"Kuzan","year":"2024","journal-title":"Marmara Medical Journal"},{"key":"2026022702201295000_16.2.363.40","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09312-x","article-title":"Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy","volume":"22","author":"Tang","year":"2022","journal-title":"BMC Cancer"},{"key":"2026022702201295000_16.2.363.41","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1080\/14796694.2024.2402215","article-title":"The prognostic value of skeletal muscle mass and density in breast cancer: a systematic review and meta-analysis","volume":"20","author":"Deng","year":"2024","journal-title":"Future Oncol"},{"key":"2026022702201295000_16.2.363.42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1551561","article-title":"Mechanisms, assessment, and exercise interventions for skeletal muscle dysfunction post-chemotherapy in breast cancer: from inflammation factors to clinical practice","volume":"15","author":"Zhong","year":"2025","journal-title":"Front Oncol"},{"key":"2026022702201295000_16.2.363.43","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1097\/NCC.0000000000000957","article-title":"The Effectiveness of Sarcopenia Interventions for Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-analysis","volume":"46","author":"Jang","year":"2023","journal-title":"Cancer Nurs"},{"key":"2026022702201295000_16.2.363.44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2022.08.009","article-title":"Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?","volume":"66","author":"Jang","year":"2022","journal-title":"Breast"},{"key":"2026022702201295000_16.2.363.45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.941496","article-title":"Body composition change during neoadjuvant chemotherapy for breast cancer","volume":"12","author":"Jang","year":"2022","journal-title":"Front Oncol"},{"key":"2026022702201295000_16.2.363.46","first-page":"4249","article-title":"Sarcopenia as a risk factor of severe laboratory adverse events in breast cancer patients receiving perioperative epirubicin plus cyclophosphamide therapy","volume":"28","author":"Ueno","year":"2020","journal-title":"Support Care Cancer"},{"key":"2026022702201295000_16.2.363.47","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering11070663","article-title":"Pretreatment Sarcopenia and MRI-Based Radiomics to Predict the Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer","volume":"11","author":"Guo","year":"2024","journal-title":"Bioengineering (Basel)"},{"key":"2026022702201295000_16.2.363.48","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0940"},{"key":"2026022702201295000_16.2.363.49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.987012","article-title":"Do body composition parameters correlate with response to targeted therapy in ER+\/HER2- metastatic breast cancer patients? Role of sarcopenia and obesity","volume":"12","author":"Kripa","year":"2022","journal-title":"Front Oncol"},{"key":"2026022702201295000_16.2.363.50","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00280-024-04641-z","article-title":"Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4\/6 inhibitors","volume":"93","author":"Y\u00fccel","year":"2024","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026022702201295000_16.2.363.51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5114\/jcb.2022.119515","article-title":"Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases","volume":"14","author":"Thormann","year":"2022","journal-title":"jcb"},{"key":"2026022702201295000_16.2.363.52","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13146"},{"key":"2026022702201295000_16.2.363.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100980"},{"key":"2026022702201295000_16.2.363.54","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/57.5.M326"},{"key":"2026022702201295000_16.2.363.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2007.07.001"},{"key":"2026022702201295000_16.2.363.56","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00080.2007"},{"key":"2026022702201295000_16.2.363.57","first-page":"586","article-title":"The relationship between sarcopenia and serum irisin and TNF-\u03b1 levels in newly diagnosed cancer patients","volume":"31","author":"Demir","year":"2023","journal-title":"Support Care Cancer"},{"key":"2026022702201295000_16.2.363.58","first-page":"3965","article-title":"The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study)","volume":"28","author":"Oflazoglu","year":"2020","journal-title":"Support Care Cancer"},{"key":"2026022702201295000_16.2.363.59","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1402300","article-title":"The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study","volume":"15","author":"Gu","year":"2025","journal-title":"Front Oncol"},{"key":"2026022702201295000_16.2.363.60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-07143-1","article-title":"Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab","volume":"12","author":"Palleschi","year":"2022","journal-title":"Sci Rep"},{"key":"2026022702201295000_16.2.363.61","doi-asserted-by":"crossref","first-page":"915","DOI":"10.6004\/jnccn.2023.7045","article-title":"Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112","volume":"21","author":"Ballinger","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"2026022702201295000_16.2.363.62","doi-asserted-by":"crossref","unstructured":"Ucgul E , Guven DC , Ucgul AN , et al . Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation. Cancer Control 2024;31. doi:10.1177\/10732748241302248","DOI":"10.1177\/10732748241302248"},{"key":"2026022702201295000_16.2.363.63","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1245\/s10434-023-13569-2","article-title":"Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis","volume":"30","author":"Masuda","year":"2023","journal-title":"Ann Surg Oncol"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-005991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:20:39Z","timestamp":1772187639000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-005991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/spcare-2025-005991"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-005991","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}